Roche, Aspreva Evaluating Filing Options For CellCept In Lupus Following Phase III Failure
Preliminary data from the induction phase of the trial show the study did not meet its primary superiority endpoint.
Preliminary data from the induction phase of the trial show the study did not meet its primary superiority endpoint.